Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment
about
Probiotics and Alcoholic Liver Disease: Treatment and Potential MechanismsLuminal Conversion and Immunoregulation by ProbioticsBreaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disordersIntestinal permeability--a new target for disease prevention and therapyMetabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal CancerIntestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky GutIncreased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel diseaseInflammatory bowel diseases: Current problems and future tasks.The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study.Intestinal inflammation and mucosal barrier function.The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.Bacterial immune interaction in experimental colitis.Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease.Consumption of Lactobacillus casei fermented milk prevents Salmonella reactive arthritis by modulating IL-23/IL-17 expressionThe structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor.Modulation of Intestinal Epithelial Defense Responses by Probiotic Bacteria.Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats.Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner.Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.Exercise and gut immune function: evidence of alterations in colon immune cell homeostasis and microbiome characteristics with exercise training.The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent.Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response.Mechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo.Lysate of Probiotic Lactobacillus plantarum K8 Modulate the Mucosal Inflammatory System in Dextran Sulfate Sodium-induced Colitic RatsInflammation and colorectal cancer: colitis-associated neoplasia.Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic viewGastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.Mapping the New World of Necrotizing Enterocolitis (NEC): Review and Opinion.Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice.Influence of orally fed a select mixture of Bacillus probiotics on intestinal T-cell migration in weaned MUC4 resistant pigs following Escherichia coli challenge.Oral Administration of Probiotics Inhibits Absorption of the Heavy Metal Cadmium by Protecting the Intestinal Barrier.Interaction with intestinal epithelial cells promotes an immunosuppressive phenotype in Lactobacillus casei.Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications.Enterococcus durans EP1 a Promising Anti-inflammatory Probiotic Able to Stimulate sIgA and to Increase Faecalibacterium prausnitzii Abundance.Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride.Two faces of microbiota in inflammatory and autoimmune diseases: triggers and drugs.Challenges in translational research on probiotic lactobacilli: from in vitro assays to clinical trials.Soluble bioactive microbial mediators regulate proteasomal degradation and autophagy to protect against inflammation-induced stress.The complex task of measuring intestinal permeability in basic and clinical science.Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases.
P2860
Q26770137-946B5680-94E3-4BBC-A279-8F6F87F0C121Q26776185-5361AA82-FA4F-4C25-9BB4-97A359A200AEQ26777279-FB113E24-02AA-4C9D-A261-CFA4DD1F7998Q27015884-C966D01A-0835-47BB-9782-7D7EEC322691Q28077783-68A2E3DF-8D1F-40F8-BBDB-5B1768581A1FQ28081848-D1047C2D-3D22-480C-948B-BBB64033608BQ30570535-83ED5179-DB95-4F5F-9A8F-6E4E5670F3D2Q34047672-0DA4D02B-8BB8-45DC-80FE-D1199C3FA161Q34292766-93D36B93-1C6C-406D-92BB-9936AC0A0B7FQ34438743-3ADB652C-5E0C-4293-BE52-577883E3AB4FQ34553267-BF9EF090-0C46-4BD5-A122-7AAA22BAEB2CQ34756171-635DFD6B-0A86-4DBB-BA35-A8571310A32EQ34813567-E740FAE6-074D-42AC-8F4E-17B531C0A376Q35067850-B3B9349E-192A-4825-86F1-A127B6C41491Q35533302-BD275163-6566-4EF8-8D0F-FCD1BB74F099Q35550764-01E327A3-CF60-4F11-BA77-D950EAF81AC7Q35666347-02C79BA0-EC4B-455B-B1D4-388D802C826DQ35719834-68B1ADB1-8E5D-431C-91F7-5EB5F8022496Q35779264-CF51F075-852A-45F7-98B6-408C88BD7415Q35857740-501166F5-77DB-4AA1-AC66-6CAAE95E8355Q35880704-8B2A3F5A-9453-48E5-8A4D-D59A7BC8FE63Q36081679-54F1F42F-BCC9-4AC5-BBB2-E31FA60A63B9Q36296995-649CAECF-B205-4B47-B767-A674F65460E1Q36325520-DBDEB084-8B33-44D6-9AAA-0D8D936434A4Q36597803-4B63AD96-D09A-408D-92BD-7EDD55245ED6Q36637753-37169200-1BD7-445E-AD68-98BF78C53AFAQ36674027-77A40263-2917-4231-8FB7-86ACE8388394Q36884751-D27E2547-47BD-4374-9041-0BAE04A01208Q37097054-1345434B-EDEB-4A4F-89E7-3C587734CF2FQ37099728-83172D46-A0FE-4A2E-80BC-C0D1EA6FEBA1Q37122238-91700EAD-D6CC-4E92-9DEA-232BA3BD09F7Q37288390-AE42E1AC-114C-408A-B3F9-9A8A197A8430Q37396622-E76B9196-BF9A-4AD0-B129-0F510CBB2EB4Q37634649-A79517BD-AAEF-4D33-86DC-8B553D493E80Q37734650-DEACEEB8-2BFC-4140-AE14-1D25BB4C276EQ38055197-D026B81E-E3AD-480E-9FCA-1A9A8138A801Q38084051-E932C0BC-09D6-405B-9636-EAAC7182FCC9Q38752414-1B222D5E-B50E-43D2-B5B2-F48FF77FA055Q38849031-D79711CE-483D-4417-8118-D2677F4CD478Q39135685-CDE13511-456D-412E-8537-32DBCE814F3D
P2860
Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@ast
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@en
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@en-gb
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@nl
type
label
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@ast
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@en
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@en-gb
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@nl
altLabel
Lysate of Probiotic Lactobacil ...... nging the Gut Microenvironment
@en
prefLabel
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@ast
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@en
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@en-gb
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@nl
P2093
P2860
P50
P3181
P1433
P1476
Lysate of probiotic Lactobacil ...... nging the gut microenvironment
@en
P2093
Dagmar Srutkova
Jakub Ridl
Jan Kopecny
Klara Klimesova
Michaela Hornova
Pavel Rossmann
Tomas Hudcovic
Zuzana Zakostelska
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0027961
P407
P577
2011-01-01T00:00:00Z